Deltex Medical Group plc (DEMG) – the USA is the way forward
Deltex Medical Group plc (DEMG), the global leader in the field of Oesophageal Doppler Monitoring (ODM), today reported its final results for the 12 months to December 31st, 2014.
As expected from the January trading update, the Group has had a tricky year. Total reported revenues for 2014 were 9% down at £6.5m (2013: £7.2m). This decrease was due largely to the challenging funding environment within the NHS where sales of ODM surgical probes fell by 20%.
Net loss also increased to £2.95m (2013: £2.1m).
More positively, the Group’s cash position at 31st December increased to £2.9m (2012: £1.5m) and they maintained a…
Previous article Next article
